# LENZ Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Jun 24, 2025

- Company: [LENZ Therapeutics, Inc.](/companies/lenz.md) (CIK 1815776)
- Form: SCHEDULE 13D/A
- Filed: 2025-06-24
- Accepted by EDGAR: Jun 24, 2025, 16:21 ET
- Period: not reported
- Accession: 0000950170-25-089455
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1815776/000095017025089455/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1815776/000095017025089455/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1815776/000095017025089455/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jun 24, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-089455. Last ingested by Listed: Nov 3, 2026, 19:08 ET. No prices; not investment advice.